Cantor Fitzgerald Investment Advisors L.P. 13F Holdings · Q3 2026
Cantor Fitzgerald Investment Advisors L.P. reported 228 securities worth $1.81B in its SEC 13F filing for Q3 2026 (period ended 2026-09-30). Top holdings: IEI (4.74%), IVV (4.47%), VOO (2.88%). Among its top 25 positions this quarter: 4 new, 14 added, 7 trimmed.
| Rank | Ticker | Company | Value | % Portfolio | Shares | Action |
|---|---|---|---|---|---|---|
| 1 | IEI | ISHARES TR | $85.8M | 4.74% | 756,408 | Trimmed |
| 2 | IVV | ISHARES TR | $81.0M | 4.47% | 105,772 | Added |
| 3 | VOO | VANGUARD INDEX FDS | $52.1M | 2.88% | 74,284 | Trimmed |
| 4 | QQQ | INVESCO QQQ TR | $48.4M | 2.68% | 65,467 | Trimmed |
| 5 | VMBS | VANGUARD SCOTTSDALE FDS | $47.3M | 2.61% | 1.1M | Trimmed |
| 6 | MSFT | MICROSOFT CORP | $43.9M | 2.43% | 85,617 | Added |
| 7 | VEA | VANGUARD TAX-MANAGED FDS | $41.3M | 2.28% | 584,724 | Trimmed |
| 8 | OKTA | OKTA INC | $32.9M | 1.82% | 157,560 | New |
| 9 | PH | PARKER-HANNIFIN CORP | $31.5M | 1.74% | 32,985 | New |
| 10 | HPE | HEWLETT PACKARD ENTERPRISE C | $30.7M | 1.70% | 480,844 | Trimmed |
| 11 | NVDA | NVIDIA CORPORATION | $30.5M | 1.68% | 133,473 | Added |
| 12 | CRM | SALESFORCE INC | $26.8M | 1.48% | 116,830 | Added |
| 13 | SCHX | SCHWAB STRATEGIC TR | $25.0M | 1.38% | 831,851 | Added |
| 14 | EMR | EMERSON ELEC CO | $22.7M | 1.25% | 146,450 | Added |
| 15 | CVS | CVS HEALTH CORP | $22.3M | 1.23% | 260,592 | Added |
| 16 | HPQ | HP INC | $22.0M | 1.22% | 704,367 | Added |
| 17 | ACN | ACCENTURE PLC IRELAND | $20.8M | 1.15% | 113,411 | Added |
| 18 | SPIB | SPDR SERIES TRUST | $20.8M | 1.15% | 645,225 | Trimmed |
| 19 | WFC | WELLS FARGO & CO | $20.8M | 1.15% | 259,999 | Added |
| 20 | JNJ | JOHNSON & JOHNSON | $19.9M | 1.10% | 75,199 | Added |
| 21 | VEEV | VEEVA SYS INC | $19.9M | 1.10% | 69,700 | New |
| 22 | VWO | VANGUARD INTL EQUITY INDEX F | $19.7M | 1.09% | 331,640 | Added |
| 23 | MET | METLIFE INC | $19.4M | 1.07% | 205,989 | Added |
| 24 | IJH | ISHARES TR | $19.3M | 1.06% | 267,642 | Added |
| 25 | REGN | REGENERON PHARMACEUTICALS | $18.9M | 1.04% | 24,900 | New |
Source: SEC Form 13F filings · as of 2026-09-30
Every position in this 13F-HR, with its change from the prior quarter.
13F holdings, latest quarter
SourceSEC EDGAR13F-HR